Implementation Supports for Improving Identification and Delivery of School-based Mental Health Supports for Middle Schools Students
Launched by UNIVERSITY OF VIRGINIA · Sep 13, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different types of training and support can help school staff better understand and address the mental health needs of middle school students. The researchers will work with middle schools using a special screening system called the Early Identification System (EIS) to see how student outcomes improve when staff receive either standard training or more in-depth support through professional learning communities and coaching.
To be eligible for this study, schools must be public middle schools that include grades 6 to 8 and are located in rural areas, towns, or cities. All students and staff at these schools can take part. Participants can expect to engage in training sessions and see how these changes impact the way mental health issues are identified and managed in their school. It's important to note that schools that have used the EIS before or have not had a good response rate in the past will not be included in the trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Public middle schools (must include grades 6-8) planning to implement the EIS
- • Located in rural areas, towns, \& suburbs / cities (NCES locales)
- • All children attending the schools and staff employed by the schools are eligible for inclusion
- Exclusion Criteria:
- • Previous use of EIS (i.e., use of all screening data and intervention hub)
- • \<70% response rate on pre-intervention implementation of EIS
About University Of Virginia
The University of Virginia (UVA) is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a focus on interdisciplinary collaboration, UVA leverages its extensive resources and expertise in various fields, including medicine, engineering, and public health, to drive cutting-edge studies that address pressing health challenges. The university's clinical trial programs aim to translate scientific discoveries into effective treatments, ensuring the highest standards of ethical practice and participant safety. Through its strong emphasis on community engagement and education, UVA fosters a culture of research that not only contributes to the scientific community but also enhances the well-being of the populations it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbia, South Carolina, United States
Columbia, Missouri, United States
Charlottesville, Virginia, United States
Patients applied
Trial Officials
Michael D Lyons, Ph.D.
Principal Investigator
University of Virginia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported